| Uric acid in metabolic syndrome: Does uric acid have a definitive role? S Copur, A Demiray, M Kanbay European journal of internal medicine 103, 4-12, 2022 | 80 | 2022 |
| Post-acute COVID-19 syndrome and kidney diseases: what do we know? S Copur, M Berkkan, C Basile, K Tuttle, M Kanbay Journal of nephrology 35 (3), 795-805, 2022 | 53 | 2022 |
| Diabetes mellitus in chronic kidney disease: biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality S Copur, EM Onal, B Afsar, A Ortiz, DH van Raalte, DZ Cherney, ... Journal of Diabetes and its Complications 34 (11), 107707, 2020 | 34 | 2020 |
| Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker S Copur, D Siriopol, B Afsar, MC Comert, G Uzunkopru, AA Sag, A Ortiz, ... Acta Diabetologica 58, 81-91, 2021 | 31 | 2021 |
| Effect of coffee consumption on renal outcome: A systematic review and meta-analysis of clinical studies M Kanbay, D Siriopol, S Copur, L Tapoi, L Benchea, M Kuwabara, ... Journal of Renal Nutrition 31 (1), 5-20, 2021 | 30 | 2021 |
| Metabolically healthy obesity: Misleading phrase or healthy phenotype? C Tanriover, S Copur, A Gaipov, B Ozlusen, RE Akcan, M Kuwabara, ... European Journal of Internal Medicine, 2023 | 18 | 2023 |
| Efficiency of hypertonic saline in the management of decompensated heart failure: a systematic review and meta-analysis of clinical studies A Covic, S Copur, L Tapoi, B Afsar, C Ureche, D Siriopol, I Nistor, ... American Journal of Cardiovascular Drugs 21, 331-347, 2021 | 18 | 2021 |
| Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease M Kanbay, MC Bulbul, S Copur, B Afsar, AA Sag, D Siriopol, M Kuwabara, ... Journal of nephrology 34, 649-659, 2021 | 16 | 2021 |
| The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta‐analysis M Kanbay, S Copur, D Siriopol, AB Yildiz, M Berkkan, KR Tuttle, C Zoccali European journal of clinical investigation 53 (1), e13878, 2023 | 14 | 2023 |
| Future of kidney imaging: Functional magnetic resonance imaging and kidney disease progression S Copur, F Yavuz, AA Sag, KR Tuttle, M Kanbay European journal of clinical investigation 52 (5), e13765, 2022 | 13 | 2022 |
| The association of acute kidney injury on outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis M Kanbay, S Copur, D Siriopol, AB Yildiz, M Berkkan, R Popa, NB Hasbal, ... Clinical Kidney Journal, 2022 | 12 | 2022 |
| SGLT-2 Inhibitors in Nephrotic Range Proteinuria: Emerging Clinical Evidence Z Kalay, OE Sahin, S Copur, S Danacı, A Ortiz, K Yau, DZI Cherney, ... Clinical Kidney Journal, 2022 | 12 | 2022 |
| Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials M Kanbay, S Copur, D Siriopol, AB Yildiz, A Gaipov, DH van Raalte, ... Diabetes, Obesity and Metabolism, 2023 | 10 | 2023 |
| The Mitochondrion: A Promising Target for Kidney Disease C Tanriover, S Copur, D Ucku, AB Cakir, NB Hasbal, MJ Soler, M Kanbay Pharmaceutics 15 (2), 570, 2023 | 9 | 2023 |
| Abdominal compartment syndrome: An often overlooked cause of acute kidney injury S Copur, M Berkkan, NB Hasbal, C Basile, M Kanbay Journal of nephrology 35 (6), 1595-1603, 2022 | 9 | 2022 |
| Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer S Copur, AA Sag, B Afsar, P Rossignol, A Covic, M Kanbay International Urology and Nephrology 52, 2311-2320, 2020 | 9 | 2020 |
| Tirzepatide and potential use for metabolically healthy obesity S Copur, C Tanriover, F Yavuz, KR Tuttle, M Kanbay European Journal of Internal Medicine, 2023 | 8 | 2023 |
| Is there any robust evidence showing that SGLT2 inhibitor use predisposes to acute kidney injury? S Copur, A Yildiz, C Basile, KR Tuttle, M Kanbay Journal of Nephrology, 1-13, 2022 | 8 | 2022 |
| The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals H Sezer, D Yazici, S Copur, T Dagel, O Deyneli, M Kanbay Blood Pressure Monitoring 26 (2), 102-107, 2021 | 8 | 2021 |
| Pathological features of COVID-19 infection from biopsy and autopsy series R ELSÜRER Tuberk Toraks 68 (2), 160-7, 2020 | 8 | 2020 |
